(Q35676581)

9 August 2017

1 reference

title

The immunological aspects of latency in tuberculosis (English)

1 reference

9 August 2017

0 references

John Chan

1

1 reference

9 August 2017

JoAnne Flynn

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

110

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

2-12

1 reference

Tuberculosis: commentary on a reemergent killer

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

The global threat of drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Tuberculosis Among Elderly Persons: An Outbreak in a Nursing Home

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

The significance of the tuberculin skin test in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Does the risk of tuberculosis increase in old age?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Mechanisms of latency in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Pathogenesis of the Sporadic Case of Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Pathogenesis of tuberculosis: pathway to apical localization

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Nitric oxide and macrophage function

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Identification of nitric oxide synthase as a protective locus against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

A novel antioxidant gene from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Peroxynitrite reductase activity of bacterial peroxiredoxins

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Inducible nitric oxide synthase in the tuberculous human lung

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Functions of lysosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

The discovery of lysosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Trafficking of lysosomal enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Acidification of the endocytic and exocytic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Phagosome maturation: aging gracefully

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Mycobacterium and the coat of many lipids

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Mycobacterium tuberculosis: here today, and here tomorrow

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Regulators of membrane trafficking and Mycobacterium tuberculosis phagosome maturation block

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Mycobacterium tuberculosis phagosome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Ultrastructural Study of the Behavior of Macrophages Toward Parasitic Mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Vesicle tethers promoting fusion machinery assembly

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Lasker Basic Medical Research Award. The machinery and principles of vesicle transport in the cell.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Membrane fusion and exocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Membrane tethering in intracellular transport

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Rab proteins as membrane organizers

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Deviant expression of Rab5 on phagosomes containing the intracellular pathogens Mycobacterium tuberculosis and Legionella pneumophila is associated with altered phagosomal fate

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Mycobacterium tuberculosis and Legionella pneumophila phagosomes exhibit arrested maturation despite acquisition of Rab7.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Cellubrevin alterations and Mycobacterium tuberculosis phagosome maturation arrest

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Cutting edge: Mycobacterium tuberculosis blocks Ca2+ signaling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

EEA1 links PI(3)K function to Rab5 regulation of endosome fusion

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

The Rab5 effector EEA1 is a core component of endosome docking

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Oligomeric complexes link Rab5 effectors with NSF and drive membrane fusion via interactions between EEA1 and syntaxin 13

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

The Rab5 effector EEA1 interacts directly with syntaxin-6

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

The FYVE domain of early endosome antigen 1 is required for both phosphatidylinositol 3-phosphate and Rab5 binding. Critical role of this dual interaction for endosomal localization

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Rabenosyn-5, a novel Rab5 effector, is complexed with hVPS45 and recruited to endosomes through a FYVE finger domain

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

A coat protein on phagosomes involved in the intracellular survival of mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

The coronin family of actin-associated proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Coronin is involved in uptake of Mycobacterium bovis BCG in human macrophages but not in phagosome maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Immunology of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Induction of direct antimicrobial activity through mammalian toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Reactivation of latent tuberculosis: variations on the Cornell murine model

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Tumor necrosis factor: a master-regulator of leukocyte movement

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

INFLIXIMAB DOWNREGULATES INTERFERON-γ PRODUCTION IN ACTIVATED GUT T-LYMPHOCYTES FROM PATIENTS WITH CROHN'S DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

Tuberculosis: latency and reactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

ExperimentalMycobacterium tuberculosisInfection of Cynomolgus Macaques Closely Resembles the Various Manifestations of HumanM. tuberculosisInfection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900210-9

7 January 2021

10.1016/S1521-6616(03)00210-9

Identifiers

DOI

1 reference

9 August 2017

1 reference